U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

AbbVie

Market Cap: US$447.7b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$307.2b

Operates as a healthcare company worldwide.

Travere Therapeutics

Market Cap: US$5.2b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Sotera Health

Market Cap: US$5.0b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Mesa Laboratories

Market Cap: US$534.1m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Ligand Pharmaceuticals

Market Cap: US$5.8b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

SIGA Technologies

Market Cap: US$249.6m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

BioLife Solutions

Market Cap: US$1.4b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Waters

Market Cap: US$35.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Repligen

Market Cap: US$8.2b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.